New heart mapping method could cut repeat ablations

NCT ID NCT05239364

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two approaches for treating atrial tachycardia that occurs after atrial fibrillation ablation or heart surgery. One group gets standard ablation targeting all abnormal heart circuits, while the other gets a more focused ablation guided by a new ultra-high-density mapping system. The goal is to see if the targeted approach reduces the chance of arrhythmia coming back. About 100 adults who have had prior AF ablation or heart surgery and now have a stable atrial tachycardia will take part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
catheter ablation (radiofrequency)
What this could lead to
If successful, this approach could reduce the number of repeat procedures needed for atrial tachycardia after atrial fibrillation treatment or heart surgery.
What could go wrong
This is an early-stage study with 100 participants, so results may not apply to all patients. The procedure carries standard risks of catheter ablation, such as bleeding or heart tissue damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARRHYTHMIAS, CARDIAC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Asklepios St. Georg

    RECRUITING

    Hamburg, Free and Hanseatic City of Hamburg, Germany

  • Evangelic Hospital Düsseldorf

    RECRUITING

    Düsseldorf, North Rhine-Westfalia, 40217, Germany

  • Evangelic Hospital Hagen-Haspe

    RECRUITING

    Hagen, Germany

  • Städtisches Klinikum Karlsruhe

    RECRUITING

    Karlsruhe, Germany

  • Universitätsklinikum Schleswig Holstein

    RECRUITING

    Kiel, Germany

  • Vivantes Klinikum Am Urban Berlin

    RECRUITING

    Berlin, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.